InvestorsHub Logo
icon url

jape1

05/13/15 3:33 AM

#344919 RE: TraderUsa #344892

OXiGENE (NASDAQ:OXGN) appoints Bill Schwieterman, M.D., as President and CEO replacing current CEO Dai Chaplin, Ph.D., who will become Chief Scientific Officer. Previously, Dr. Schwieterman was Chief Medical Officer at Chelsea Therapeutics.